Liquidación masiva de las EPS, un riesgo latente pero alternativa inviable
Foro Mesa de expertos, retos del sistema de salud: el rol de los prestadores y aseguradores en su sostenibilidad. Foto: @MiltonDiazfoto / El Tiempo
TL;DR
- The discussion around Colombia's healthcare system has narrowly focused on payment issues and lack of resources, overshadowing other structural problems.
- The private sector is a key player, supporting financial resolutions and patient access, and is open to increased oversight.
- Financial deterioration is affecting the entire healthcare chain, from medication supply to continuity of treatments, impacting patients directly.
- Lack of payment is causing medication shortages, a direct consequence of economic issues within the system.
- Reduced contributions from companies and increased demand for services are straining the system's revenue.
- The current crisis is seen as both financial and a result of institutional decisions that have weakened the system.
- A call for immediate financial stabilization measures is urgent, as is the need to address the underlying causes of the crisis.
- Discrepancies in reported figures for the system's deficit highlight a lack of clear understanding of the crisis.
- The financial state of intervened EPS is critical, with significant liabilities and negative equity, posing a risk of mass liquidations.
- Structural pressures on financing are evident in affiliation figures and the reliance on state fiscal efforts.
- The need for robust information systems and interoperability is crucial for advancing the healthcare system and controlling spending.
- Without immediate decisions and a constructive conversation, the system faces a potential collapse.
- Redirection of funds, such as those for basic equipment previously funded by UPC, could provide some much-needed resources.